Kassidy Blanton
Family Medicine · Shelby, NCNPI 1457950818
Payments from drug & device makers
Across 88 payments — averaging $14.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$311
- Novartis$172
- Biohaven Pharmaceuticals, Inc.$89
- Sanofi-aventis U.S. LLC$88
- Amarin Pharma, Inc.$87
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$82
- plus $437 from 12 others
What the payments were for
- Food & beverage$1,266100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $311 |
| Novartis | 10 | $172 |
| Biohaven Pharmaceuticals, Inc. | 5 | $89 |
| Sanofi-aventis U.S. LLC | 5 | $88 |
| Amarin Pharma, Inc. | 5 | $87 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $82 |
| Amgen | 4 | $73 |
| Endo USA, Inc. | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $65 |
| Lilly USA, LLC | 4 | $53 |
| Boehringer Ingelheim | 3 | $42 |
| AstraZeneca | 3 | $36 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $15 |
| Organon | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$1,266 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 54 | $399 |
| Doxycycline Hyclate | 42 | $352 |
| Tamsulosin Hcl | 36 | $322 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $292 |
| Cephalexin | 61 | $246 |
| Cefdinir | 16 | $240 |
| Fluticasone Propionate | 23 | $194 |
| Prednisone | 49 | $177 |
| Mupirocin | 14 | $124 |
| Fluconazole | 11 | $109 |
| Methylprednisolone | 11 | $79 |
| Azithromycin | 22 | $70 |
| Ciprofloxacin Hcl | 11 | $66 |
| Amoxicillin | 13 | $52 |
| Triamcinolone Acetonide | 13 | $40 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Shelby
- Christian MartinShelby$5.4M
- Stephen JonesShelby$4.5M
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.